Leaflet MUCONASAL SPRAY 1.18mg / ml nasal spray, solution

Product code:
W68004001
Quantity:
1
Indicated for:
nasal congestion; rhinitis
Route of administration:
nasal
Substance:
tramazoline (adrenergic decongestant)
ATC
R01AA09 — Respiratory system | Decongestants and other nasal preparations for topical use | Sympathomimetics, plain
Tramazoline is a nasal decongestant used to relieve nasal congestion associated with acute rhinitis, sinusitis, or other respiratory conditions. It works by stimulating alpha-adrenergic receptors in the nasal mucosa, causing vasoconstriction and reducing swelling.

Tramazoline is available as a nasal spray or drops and is administered locally, usually 2-3 times a day, for a limited period (maximum 7 days) to avoid the risk of rebound congestion (rhinitis medicamentosa).

Common side effects include nasal dryness, a burning sensation, or local irritation. In rare cases, systemic adverse reactions such as hypertension, tachycardia, or insomnia may occur, especially with excessive use. It is important for patients to follow the recommended dosage and avoid prolonged use.

Tramazoline is an effective and well-tolerated option for the rapid relief of nasal congestion, contributing to improved breathing and patient comfort.

General data about MUCONASAL SPRAY 1.18mg / ml

Substance:
tramazoline
Date of latest medicines list:
01-10-2021
Product code:
W68004001
Concentration:
1.18mg / ml
Pharmaceutical form:
nasal spray, solution
Packing volume:
10 ml
Product type:
Original
Prescription status:
OTC — Over the Counter = medicine that does not require a medical prescription.

Marketing authorisation

Manufacturer:
ISTITUTO DE ANGELI SRL - ITALIA
Holder:
OPELLA HEALTHCARE ROMANIA SRL - ROMANIA
Number:
882/2008/01
Shelf life:
3 years